Open AccessEmbryo/Fetus doses from 18F-fludeoxyglucose radiopharmaceutical in positron emission tomography/computed tomography
Author(s) -
NazeninIpek Isikci,
Mustafa Demır
Publication year - 2022
Publication title -
journal of medical physics/journal of medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 24
eISSN - 1998-3913
pISSN - 0971-6203
DOI - 10.4103/jmp.jmp_115_21
Subject(s) - nuclear medicine , fetus , positron emission tomography , medicine , embryo , ionizing radiation , tomography , dosimetry , pregnancy , radiology , physics , irradiation , biology , genetics , microbiology and biotechnology , nuclear physics
The embryo/fetus may be accidentally exposed to ionizing radiation. The aim of this study is to calculate embryo/fetus doses in pregnant women who underwent F-18 fludeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan.